{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:48:33Z","timestamp":1791935313223,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The program for Guangdong Introducing Innovative and Entrepreneurial Teams","award":["2019ZT08Y297"],"award-info":[{"award-number":["2019ZT08Y297"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Available biomarkers lack sensitivity for an early lung cancer. Circulating genetically abnormal cells (CACs) occur early in tumorigenesis. To determine the diagnostic value of CACs in blood detected by 4-color fluorescence in situ hybridization (FISH) for lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective study of patients with pulmonary nodules\u2009\u2264\u200930\u00a0mm detected between 10\/2019 and 01\/2020 at four tertiary hospitals in China. All patients underwent a pathological examination of lung nodules found by imaging and were grouped as malignant and benign. CACs were detected by 4-color FISH. Patients were divided into the training and validation cohorts. Receiver operating characteristics analysis was used to analyze the diagnosis value of CACs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 205 participants were enrolled. Using a cut-off value of\u2009\u2265\u20093, blood CACs achieved areas under the curve (AUCs) of 0.887, 0.823, and 0.823 for lung cancer in the training and validation cohorts, and all patients, respectively. CACs had high diagnostic values across all tumor sizes and imaging lesion types. CACs were decreased after surgery (median, 4 vs. 1,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) in the validation set. The CAC status between blood and tissues was highly consistent (kappa\u2009=\u20090.909,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The AUC of CAC (0.823) was higher than that of CEA (0.478), SCC (0.516), NSE (0.506), ProGRP (0.519), and CYFRA21-1 (0.535) (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CACs might have a high value for the early diagnosis of lung cancer. These findings might need to be validated in future studies. Evidence suggested homology in genetic aberrations between the CACs and the tumor cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00432-021-03517-6","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T19:04:45Z","timestamp":1612811085000},"page":"2397-2405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer"],"prefix":"10.1007","volume":"147","author":[{"given":"Mingxiang","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baishen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanci","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuoji","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-5002","authenticated-orcid":false,"given":"Chunxue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,6]]},"reference":[{"key":"3517_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68:394\u2013424 doi:https:\/\/doi.org\/10.3322\/caac.21492","DOI":"10.3322\/caac.21492"},{"key":"3517_CR2","unstructured":"Cancer du poumon, Bilan initial, Collection Recommandations et r\u00e9f\u00e9rentiels (2011). INCa, Boulogne-Billancourt"},{"key":"3517_CR3","doi-asserted-by":"publisher","first-page":"31985","DOI":"10.1038\/srep31985","volume":"6","author":"KZ Chen","year":"2016","unstructured":"Chen KZ et al (2016) Circulating tumor DNA detection in early-stage non-small cell lung cancer patients by targeted sequencing. Sci Rep 6:31985. https:\/\/doi.org\/10.1038\/srep31985","journal-title":"Sci Rep"},{"key":"3517_CR4","doi-asserted-by":"publisher","unstructured":"Evangelista et al (2012) Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET\/CT. J Med Imaging Radiat Oncol 56:417\u2013424 doi: https:\/\/doi.org\/10.1111\/j.1754-9485.2012.02408.x","DOI":"10.1111\/j.1754-9485.2012.02408.x"},{"key":"3517_CR5","doi-asserted-by":"publisher","unstructured":"Haruki et al (2001) Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation. Am J Pathol 159:1345\u20131352 doi:https:\/\/doi.org\/10.1016\/S0002-9440(10)62521-7","DOI":"10.1016\/S0002-9440(10)62521-7"},{"key":"3517_CR6","first-page":"5","volume":"7","author":"FR Hirsch","year":"2001","unstructured":"Hirsch FR, Franklin WA, Gazdar AF, Bunn PA Jr (2001) Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 7:5\u201322","journal-title":"Clin Cancer Res"},{"key":"3517_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1593\/neo.04142","volume":"6","author":"F Jiang","year":"2004","unstructured":"Jiang F, Yin Z, Caraway NP, Li R, Katz RL (2004) Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia 6:623\u2013635. https:\/\/doi.org\/10.1593\/neo.04142","journal-title":"Neoplasia"},{"key":"3517_CR8","doi-asserted-by":"publisher","unstructured":"Katz et al (2020) Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules. Cancer Cytopathol doi:https:\/\/doi.org\/10.1002\/cncy.22278","DOI":"10.1002\/cncy.22278"},{"key":"3517_CR9","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1158\/1078-0432.CCR-09-3358","volume":"16","author":"RL Katz","year":"2010","unstructured":"Katz RL et al (2010) Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res 16:3976\u20133987. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-3358","journal-title":"Clin Cancer Res"},{"key":"3517_CR10","first-page":"214","volume":"48","author":"SK Kim","year":"2007","unstructured":"Kim SK et al (2007) Accuracy of PET\/CT in characterization of solitary pulmonary lesions. J Nucl Med 48:214\u2013220","journal-title":"J Nucl Med"},{"key":"3517_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.chest.2018.01.016","volume":"153","author":"PJ Mazzone","year":"2018","unstructured":"Mazzone PJ et al (2018) Screening for lung cancer: CHEST guideline and expert panel report. Chest 153:954\u2013985. https:\/\/doi.org\/10.1016\/j.chest.2018.01.016","journal-title":"Chest"},{"key":"3517_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cancers2010190","volume":"2","author":"A Mishra","year":"2010","unstructured":"Mishra A, Verma M (2010) Cancer biomarkers: are we ready for the prime time? Cancers (Basel) 2:190\u2013208. https:\/\/doi.org\/10.3390\/cancers2010190","journal-title":"Cancers (Basel)"},{"key":"3517_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/M13-2771","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA, Force USPST (2014) Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 160:330\u2013338. https:\/\/doi.org\/10.7326\/M13-2771","journal-title":"Ann Intern Med"},{"key":"3517_CR14","doi-asserted-by":"publisher","unstructured":"National Lung Screening Trial Research T et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395\u2013409 doi:https:\/\/doi.org\/10.1056\/NEJMoa1102873","DOI":"10.1056\/NEJMoa1102873"},{"key":"3517_CR15","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Lung Cancer Screening. (2019). Version 1.2020 edn. National Comprehensive Cancer Network, Washington"},{"key":"3517_CR16","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Non-Small Cell Lung Cancer. (2020). Version 4.2020 edn. National Comprehensive Cancer Network, Washington"},{"key":"3517_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrclinonc.2014.222","volume":"12","author":"JW Neal","year":"2015","unstructured":"Neal JW, Gainor JF, Shaw AT (2015) Developing biomarker-specific end points in lung cancer clinical trials. Nat Rev Clin Oncol 12:135\u2013146. https:\/\/doi.org\/10.1038\/nrclinonc.2014.222","journal-title":"Nat Rev Clin Oncol"},{"key":"3517_CR18","doi-asserted-by":"publisher","unstructured":"Novello et al (2016) Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 27:v1-v27 doi:https:\/\/doi.org\/10.1093\/annonc\/mdw326","DOI":"10.1093\/annonc\/mdw326"},{"key":"3517_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.21037\/tlcr.2017.07.03","volume":"6","author":"L O'Flaherty","year":"2017","unstructured":"O\u2019Flaherty L, Wikman H, Pantel K (2017) Biology and clinical significance of circulating tumor cell subpopulations in lung cancer. Transl Lung Cancer Res 6:431\u2013443. https:\/\/doi.org\/10.21037\/tlcr.2017.07.03","journal-title":"Transl Lung Cancer Res"},{"key":"3517_CR20","doi-asserted-by":"publisher","unstructured":"Pailler et al (2015) High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer. Ann Oncol 26:1408\u20131415 doi:https:\/\/doi.org\/10.1093\/annonc\/mdv165","DOI":"10.1093\/annonc\/mdv165"},{"key":"3517_CR21","doi-asserted-by":"publisher","unstructured":"Patel et al (2013a) A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest 143:825\u2013839 doi:https:\/\/doi.org\/10.1378\/chest.12-0960","DOI":"10.1378\/chest.12-0960"},{"key":"3517_CR22","doi-asserted-by":"publisher","unstructured":"Patel et al (2013b) A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm. Chest 143:840\u2013846 doi:https:\/\/doi.org\/10.1378\/chest.12-1487","DOI":"10.1378\/chest.12-1487"},{"key":"3517_CR23","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1126\/science.1235226","volume":"341","author":"V Plaks","year":"2013","unstructured":"Plaks V, Koopman CD, Werb Z (2013) Cancer. Circulating tumor cells. Science 341:1186\u20131188. https:\/\/doi.org\/10.1126\/science.1235226","journal-title":"Science"},{"key":"3517_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s1525-1578(10)60459-x","volume":"5","author":"MS Romeo","year":"2003","unstructured":"Romeo MS et al (2003) Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. J Mol Diagn 5:103\u2013112. https:\/\/doi.org\/10.1016\/s1525-1578(10)60459-x","journal-title":"J Mol Diagn"},{"key":"3517_CR25","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1378\/chest.111.6.1691","volume":"111","author":"T Schenk","year":"1997","unstructured":"Schenk T, Ackermann J, Brunner C, Schenk P, Zojer N, Roka S, Drach J (1997) Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients. Chest 111:1691\u20131696. https:\/\/doi.org\/10.1378\/chest.111.6.1691","journal-title":"Chest"},{"key":"3517_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.lungcan.2016.04.026","volume":"107","author":"L Sorber","year":"2017","unstructured":"Sorber L et al (2017) Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Lung Cancer 107:100\u2013107. https:\/\/doi.org\/10.1016\/j.lungcan.2016.04.026","journal-title":"Lung Cancer"},{"key":"3517_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0165-4608(95)00355-x","volume":"89","author":"T Taguchi","year":"1996","unstructured":"Taguchi T, Zhou JY, Feder M, Litwin S, Klein-Szanto AJ, Testa JR (1996) Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes. Cancer Genet Cytogenet 89:120\u2013125. https:\/\/doi.org\/10.1016\/0165-4608(95)00355-x","journal-title":"Cancer Genet Cytogenet"},{"key":"3517_CR28","doi-asserted-by":"publisher","first-page":"6980","DOI":"10.1158\/1078-0432.CCR-09-1095","volume":"15","author":"F Tanaka","year":"2009","unstructured":"Tanaka F et al (2009) Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res 15:6980\u20136986. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1095","journal-title":"Clin Cancer Res"},{"key":"3517_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrc.2016.56","volume":"16","author":"AJ Vargas","year":"2016","unstructured":"Vargas AJ, Harris CC (2016) Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer 16:525\u2013537. https:\/\/doi.org\/10.1038\/nrc.2016.56","journal-title":"Nat Rev Cancer"},{"key":"3517_CR30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1164\/rccm.200602-160OC","volume":"174","author":"JP Wisnivesky","year":"2006","unstructured":"Wisnivesky JP, Henschke CI, Yankelevitz DF (2006) Diagnostic percutaneous transthoracic needle biopsy does not affect survival in stage I lung cancer. Am J Respir Crit Care Med 174:684\u2013688. https:\/\/doi.org\/10.1164\/rccm.200602-160OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3517_CR31","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1378\/chest.126.3.744","volume":"126","author":"T Yamagami","year":"2004","unstructured":"Yamagami T, Kato T, Iida S, Hirota T, Nishimura T (2004) Percutaneous needle biopsy for small lung nodules beneath the rib under CT scan fluoroscopic guidance with gantry tilt. Chest 126:744\u2013747. https:\/\/doi.org\/10.1378\/chest.126.3.744","journal-title":"Chest"},{"key":"3517_CR32","doi-asserted-by":"publisher","unstructured":"Yamauchi et al. (2011) Diagnostic performance of percutaneous core-needle lung biopsy under CT scan fluoroscopic guidance for pulmonary lesions measuring <\/=10 mm. Chest 140:1669\u20131670 doi:https:\/\/doi.org\/10.1378\/chest.11-1821","DOI":"10.1378\/chest.11-1821"},{"key":"3517_CR33","doi-asserted-by":"publisher","unstructured":"Yendamuri et al. (2008) 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung. Cancer (NSCLC) J Thorac Oncol 3:979\u2013984 doi:https:\/\/doi.org\/10.1097\/JTO.0b013e3181834f3a","DOI":"10.1097\/JTO.0b013e3181834f3a"},{"key":"3517_CR34","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.physiol.64.081501.155828","volume":"64","author":"S Zochbauer-Muller","year":"2002","unstructured":"Zochbauer-Muller S, Gazdar AF, Minna JD (2002) Molecular pathogenesis of lung cancer. Annu Rev Physiol 64:681\u2013708. https:\/\/doi.org\/10.1146\/annurev.physiol.64.081501.155828","journal-title":"Annu Rev Physiol"},{"key":"3517_CR35","doi-asserted-by":"publisher","unstructured":"Zojer N, Dekan G, Ackermann J, Fiegl M, Kaufmann H, Drach J, Huber H (2000) Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation. Lung Cancer 28:225\u2013235 doi:https:\/\/doi.org\/10.1016\/s0169-5002(00)00097-0","DOI":"10.1016\/s0169-5002(00)00097-0"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03517-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03517-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03517-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T08:03:55Z","timestamp":1624781035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03517-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,6]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03517-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-69939\/v1","asserted-by":"object"}]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,6]]},"assertion":[{"value":"26 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has been approved by the ethics committee of Zhongshan Hospital Affiliated to Fudan University (b2019-185r) and by the ethics review committees of the three other hospitals. Written inform consent was provided by all participants before the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}